POST https://chat.qwen.ai/api/chat/completions HTTP/2.0
content-length: 408
x-request-id: 00487ddc-adcc-4437-b40c-58f2e5bf3a0a
authorization: Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpZCI6ImM4NWUwZGQ3LTQ3MzEtNDA0MC1hNjMxLWM4Njk1N2NkOTJiOCIsImV4cCI6MTc0NDI0NTEyNX0.hTiz8DaSdULD2Pk3DXwuQhHRgFEyUkUF0hO7PVHsBpY
bx-umidtoken: T2gAZ3ZL8TtNttRENoJsl-vMXwryTzvwv683NlcjFoi8W5u78aDhpC_ueu47TOMl1Jo=
x-accel-buffering: no
sec-ch-ua: "Chromium";v="134", "Not:A-Brand";v="24", "Google Chrome";v="134"
bx-ua: 231!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
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "macOS"
source: web
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/134.0.0.0 Safari/537.36
content-type: application/json
version: 0.0.48
bx-v: 2.5.28
accept: */*
origin: https://chat.qwen.ai
sec-fetch-site: same-origin
sec-fetch-mode: cors
sec-fetch-dest: empty
referer: https://chat.qwen.ai/
accept-encoding: gzip, deflate, br, zstd
accept-language: en-US,en;q=0.9
cookie: _gcl_au=1.1.1984752171.1741653092
cookie: cna=Z3JWIKfELRQCAUQ9ZB/z3ld9
cookie: xlly_s=1
cookie: _bl_uid=1vmwq8XU5m15zX7U9w4FdbI9LbaF
cookie: acw_tc=6bfdd88139b5b65a24fd4df3597f43ed5ae62bd8935a6203cc3fdf97b12ed399
cookie: x-ap=us-west-1
cookie: token=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpZCI6ImM4NWUwZGQ3LTQ3MzEtNDA0MC1hNjMxLWM4Njk1N2NkOTJiOCIsImV4cCI6MTc0NDQxMDU2NH0.eibY8SdXqA6pLvX-PZV7OX3pawFZvELbbDQKS7tXVfY
cookie: ssxmod_itna=QqAx9D2DgAYYqD5i7di=iv4iIqCq0jxDXDUqAQD2DITq7=GFCDCOIiTeEwDx+XR7i55t0rD5D/iWrmoDUZ4iaDIbmq4DGxvhtHLG7rbN=3RZA+shXzZAxG5LABB0me3s9iaY+DnmeDwxib=xD1IDDk+A5DxxGTDCeDQxirDD4DAAYD0pEhIDDdW97maUvoq3hhW4GWtEhoDY5jDATAk9opMgDAicm3O8+sDm95xk+KW4Ga0fb0DlFTDmRrt9CuDC964SvQHfovID6Yqj9B+mae+Wrbq0w47=GxKOPxeADMHhGr0TXZHxrPwDxIkGKxDiotrYXjiGxief16jcm6pYCAUcC2wmpK+GxlXhnwfGq10qs0PSOeBAGBom3imLYD
cookie: ssxmod_itna2=QqAx9D2DgAYYqD5i7di=iv4iIqCq0jxDXDUqAQD2DITq7=GFCDCOIiTeEwDx+XR7i55t0rieDAeah0GrHKD7pxdGUjoD/iiAqnHKfWPDQH570DWqtG/7G4pQMGdCaYrvfA3ljYAkvSGjILwxIuhpG+D49qfxdl00eojp7YL3U3QqWWLdMDhjWeT=xeTq/mT5R8ntTZbqGARFdPxa6eh3eOD+Geb+ROvzGA+t4drw9ae+naD
cookie: SERVERID=bc688e2700b0feca296b9a4b1b0e5a28|1741818571|1741818257
cookie: tfstk=g8_nMA0URdMjfZBxpO8QDPlJxhZORXTWmT3JeUpzbdJ1JTEBeGYPgtxJ4ksdIX_Gn43Ldk1rrULzH-UYk6GBPUyAuwiqJXOJaXorep8ZbUduUfCtg61BPfwCaSCCOYmkJF1yzT8wbIAXz0-r85YwiQ8r83uEbAJ6aU8yLQuZ7QASY2-E85fwCQ8yUT-er6g2p1Cc7RrcXscwHhQMtHvV_PirqN3vvK5eI-kOSBvX36Jiz4vKMlbNaTyoyESfIaxVHz06Jsjw7BjgacJemMWp1T4m8p7GTwJd8R3pLw1NDaBaa4Jlbi-A06ytjCjN9NxOu-0kAGWCc3b8BrTdDsQW0wznhdKXZtYFjRuh3gSnbmoA14OawNoSVHR6sKB2nllYGcwqR5Vi0hte1BrUs5m7bHR6sQPgsmlDYCO3D
cookie: isg=BKSkHrdMn8UwmuuU6tKFKJ41daSWPcinUyBnzr7FM28yaUcz9knQNuZPLNnxnwD_
priority: u=1, i

{"stream":true,"incremental_output":true,"chat_type":"search","model":"qwen-max-latest","messages":[{"role":"user","content":"2008年肝素污染危機是誰的錯？","chat_type":"search","extra":{},"feature_config":{"thinking_enabled":false}}],"session_id":"f0e52528-9add-467a-a1a5-1a6b455ba062","chat_id":"7b6f8760-5456-4cbb-af92-deb9e4209250","id":"dfe0918a-336a-48fc-915b-d039bb51150c","size":"960*960"}HTTP/2.0 200 
date: Wed, 12 Mar 2025 22:29:33 GMT
content-type: text/event-stream;charset=UTF-8
vary: Accept-Encoding
access-control-allow-credentials: true
access-control-allow-origin: https://chat.qwen.ai
vary: Origin
x-request-id: 00487ddc-adcc-4437-b40c-58f2e5bf3a0a
cache-control: no-cache
set-cookie: x-ap=us-west-1; Path=/; SameSite=lax
x-process-time: 2
set-cookie: SERVERID=bc688e2700b0feca296b9a4b1b0e5a28|1741818571|1741818257;Path=/
set-cookie: SERVERCORSID=bc688e2700b0feca296b9a4b1b0e5a28|1741818571|1741818257;Path=/;SameSite=None
content-encoding: br
ga-ap: us-west-1

data: {"choices": [{"delta": {"role": "assistant", "content": "", "function_call": {"name": "web_search", "arguments": ""}}}]}

data: {"choices": [{"delta": {"role": "function", "content": "", "name": "web_search", "extra": {"web_search_info": [{"url": "https://wap.eastmoney.com/a/20160918664661420.html", "title": "被FDA 签发483缺陷表健友股份招股书未披露引争议 - 东方财富", "snippet": "这是继2008年百特肝素钠污染事件后，涉及肝素领域的又一重磅事件，中国原料药企再度遭遇出口信任危机。 有业内人士提醒道：“鉴于中国这一药企的违规记录，不", "hostname": "东方财富网", "hostlogo": "https://img.alicdn.com/imgextra/i1/O1CN01iL4mYC1cF6vgiem0A_!!6000000003570-55-tps-32-32.svg", "date": " (2016-09-18)"}, {"url": "https://q.stock.sohu.com/cn,gg,002399,1703423197.shtml", "title": "公司公告-海普瑞：重大资产购买报告书（草案）摘要 - 搜狐股票", "snippet": "责任。 （四）肝素事件相关诉讼风险2008 年的肝素事件引发了针对肝素制剂及原料生产厂商百特公司、SPL 等的大量诉讼。截至《股权购买协议》签署之日", "hostname": "搜狐", "hostlogo": "https://img.alicdn.com/imgextra/i2/O1CN01veTqEW21FRbz3biWe_!!6000000006955-55-tps-32-32.svg", "date": " (2014-01-13)"}, {"url": "https://international.caixin.com/2008-04-30/100062586.html", "title": "美国会质询“肝素钠不良反应事件”", "snippet": "今年3月19日，美国药监局宣布，百特公司问题肝素钠中存在的“神秘污染物”为一种廉价的、未经审批的化学活性成分，名为“多硫酸软骨素（oversulfated chondroitin", "hostname": "财新网", "hostlogo": "https://img.alicdn.com/imgextra/i2/O1CN01oWqr251caB9yMliXs_!!6000000003616-73-tps-16-16.ico", "date": " (2008-04-30)"}, {"url": "https://jcpu.cpu.edu.cn/cn/article/pdf/preview/10.11665/j.issn.1000-5048.20220316.pdf", "title": "[PDF] 《动物来源药用辅料指导原则》解析 - 中国药科大学学报", "snippet": "以2008 年发生在美国的“肝素钠”事. 件为例，美国百特公司生产的多批次肝素钠多剂. 量瓶装注射液中检出一种类肝素物质污染物多. 硫酸软骨素，并被证明与患者注射后发生过敏", "hostname": null, "hostlogo": null, "date": ""}, {"url": "https://patents.google.com/patent/CN115448994A/zh", "title": "CN115448994A - 一种可中和抗凝低分子量肝素及其制备方法和应用", "snippet": "污染并转移到最终药品的风险。如2007年至2008年出现的肝素钠危机，原因是被混入多硫酸软骨素的肝素和低分子量肝素进入市场，仅在美国就造成近百人死亡，考虑到肝素在", "hostname": null, "hostlogo": null, "date": ""}]}}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "200"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "8年肝素污染危机"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "是一起涉及多"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "方面责任的事件"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "，主要与美国"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "百特公司（Baxter"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "）生产的肝素钠"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "注射液中发现"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "的污染物有关。以下是"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "事件中各方的责任分析"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "：\n\n1. **污染物"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "来源**：  \n"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "   美国"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "食品药品监督管理局（"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "FDA）在调查"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "后确认，肝素"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "钠中的“神秘污染物”"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "为一种廉价且"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "未经审批的化学物质"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "——多硫酸软骨素"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "（oversulfated chond"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "roitin sulfate）。"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "这种物质被混"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "入肝素原料"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "中，以降低成本[["}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "3]]。这"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "表明，问题的根源在于"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "供应链中的原料掺"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "假行为。\n\n2."}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": " **中国原料药企业的"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "责任**：  \n   "}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "百特公司的肝素原料"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "部分来源于中国的供应商"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。事件发生后，中国"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "原料药企因"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "质量控制不严"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "和违规记录而受到"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "质疑，甚至引发了"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "对中国原料药行业的信任"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "危机[[1]]。尽管"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "具体掺假行为"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "可能并非由中国企业直接"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "实施，但其"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "未能有效监管供应链"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "，确实负有一定"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "责任。\n\n3. **百"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "特公司的责任**："}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "  \n   作为最终"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "药品的生产商，百特"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "公司对产品质量负有直接"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "责任。然而，在"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "事件中，百特公司"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "声称其遵循了FDA"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "的相关规定，并未"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "预料到供应链中会出现如此"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "严重的掺假行为"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "[[2]]。尽管"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "如此，百特公司在"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "原料采购和质量"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "控制环节可能存在疏漏，"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "这也是导致危机的重要原因"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。\n\n4. **监管"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "机构的责任**："}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "  \n   FDA在事件"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "中也受到了批评，因其"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "未能及时发现并阻止"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "问题产品的流通。"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "此外，FDA在肝素"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "原料的检测方法"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "上存在漏洞，未能识别"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "出多硫酸软骨"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "素这一污染物[[4"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "]]。这暴露"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "了监管体系在应对"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "复杂供应链时的不足"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。\n\n### 结论：\n"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "2008年肝"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "素污染危机是多方"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "责任叠加的结果。中国"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "原料药供应商因"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "掺假行为和"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "质量控制不严"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "负有重要责任，百"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "特公司在供应链管理和质量控制"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "上存在疏漏，而"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "FDA则因监管漏洞"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "未能有效防范风险"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。这一事件凸显"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "了全球药品供应链中质量"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "控制和监管的重要性[["}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "5]]。"}}]}

